PCI versus CABG in coronary artery disease

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Recent large trials and registries have strengthened the evidence for percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in coronary artery disease (CAD).
• CABG demonstrates significant survival advantages and reduced risks of myocardial infarction and repeat revascularization compared to PCI.

Discussion:

• CABG benefits are most pronounced in multivessel disease with intermediate to high severity, and in left main disease with the highest severity.
• These advantages are amplified in patients with diabetes and/or impaired ventricular function.
• The 'Heart Team' approach, involving multidisciplinary input, is recommended for treatment decisions in stable or urgent clinical settings.

Key Insights:

• CABG provides superior long-term survival and reduces adverse cardiac events compared to PCI in specific patient subgroups.
• Patient-specific factors, including disease severity, comorbidities (diabetes, ventricular dysfunction), and patient preferences, are critical in guiding revascularization strategy.
• Multidisciplinary collaboration ensures comprehensive evaluation and personalized treatment planning.

Outlook:

• Further research may refine risk stratification and identify optimal patient profiles for each revascularization strategy.
• Advancements in both PCI and CABG techniques continue to evolve, potentially altering the comparative effectiveness landscape.
• Personalized medicine approaches, guided by the Heart Team, will likely dominate future decision-making in complex coronary artery disease management.